TY - JOUR
T1 - Long-term visual outcomes following lens-sparing vitrectomy for retinopathy of prematurity
AU - Singh, Ruhi
AU - Reddy, Deepthi M.
AU - Barkmeier, Andrew Jonathan
AU - Holz, Eric
AU - Ram, Radha
AU - Carvounis, Petros Euthymiou
PY - 2012/11
Y1 - 2012/11
N2 - Aim: To describe the long-term outcomes of lens-sparing vitrectomy (LSV) for retinopathy of prematurity (ROP). Method:s Single-centre retrospective case series of eyes that underwent LSV for ROP between 1998 and 2005 and had a follow-up of at least 5 years. The primary outcome was the mean visual acuity, and secondary outcomes were the proportion of eyes without functional vision, proportion of eyes with anatomic success, proportion of Stage 4A eyes with vision better than 20/400, proportion of Stage 4B eyes with vision better than 20/800. Results: Thirty-seven eyes of 30 patients (mean age at last follow-up: 7.1 years) were included in the study, while an additional 23 patients had been lost to followup and were not included in the study. Of eyes that underwent LSV for Stage 4A or 4B: 63% had measurable visual acuity (mean logMAR 0.92 for Stage 4A, 1.63 for Stage 4B), 19% had form vision, but neurological comorbidities precluded visual acuity measurement, and the remaining 18% had light perception or no light perception. Conclusions: While most eyes that underwent LSV for Stage 4A or 4B ROP maintain useful vision with longterm follow-up, approximately one-fifth of eyes had no functional vision, and in a further fifth, vision could not be measured due to severe neurological impairment.
AB - Aim: To describe the long-term outcomes of lens-sparing vitrectomy (LSV) for retinopathy of prematurity (ROP). Method:s Single-centre retrospective case series of eyes that underwent LSV for ROP between 1998 and 2005 and had a follow-up of at least 5 years. The primary outcome was the mean visual acuity, and secondary outcomes were the proportion of eyes without functional vision, proportion of eyes with anatomic success, proportion of Stage 4A eyes with vision better than 20/400, proportion of Stage 4B eyes with vision better than 20/800. Results: Thirty-seven eyes of 30 patients (mean age at last follow-up: 7.1 years) were included in the study, while an additional 23 patients had been lost to followup and were not included in the study. Of eyes that underwent LSV for Stage 4A or 4B: 63% had measurable visual acuity (mean logMAR 0.92 for Stage 4A, 1.63 for Stage 4B), 19% had form vision, but neurological comorbidities precluded visual acuity measurement, and the remaining 18% had light perception or no light perception. Conclusions: While most eyes that underwent LSV for Stage 4A or 4B ROP maintain useful vision with longterm follow-up, approximately one-fifth of eyes had no functional vision, and in a further fifth, vision could not be measured due to severe neurological impairment.
UR - http://www.scopus.com/inward/record.url?scp=84868121380&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84868121380&partnerID=8YFLogxK
U2 - 10.1136/bjophthalmol-2011-301353
DO - 10.1136/bjophthalmol-2011-301353
M3 - Article
C2 - 22923456
AN - SCOPUS:84868121380
SN - 0007-1161
VL - 96
SP - 1395
EP - 1398
JO - British Journal of Ophthalmology
JF - British Journal of Ophthalmology
IS - 11
ER -